drugset / Trial / NCT00729404

Inhibition of Ovulation, Patch, Ethinylestradiol and Gestodene

NCT00729404

Phase 2 Terminated 17 enrolled Bayer
RandomizedParallel-groupOpen-labelTreatment

Summary

Investigation of two transdermal hormone patch formulations for contraception regarding inhibition of ovulation over a period of 3 treatment cycles in healthy young female volunteers

Timeline

Start
2008-08
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Gestodene Small molecule 1.05 mg Other
Subject Gestodene Small molecule 2.1 mg Other
Subject ethinyl estradiol Small molecule 0.55 mg Other

Indications